{
    "2019-04-10": [
        [
            {
                "time": "2018-05-08",
                "original_text": "What Alconâ€™s Spinoff Can Teach Bausch Health",
                "features": {
                    "keywords": [
                        "Alcon",
                        "spinoff",
                        "Bausch",
                        "Health"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "5 Companies Paying High Dividend Yields",
                "features": {
                    "keywords": [
                        "dividend",
                        "yields"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-26",
                "original_text": "Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Amgen",
                        "FDA",
                        "approval",
                        "Evenity"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-30",
                "original_text": "Alcon Can See Clearly Now",
                "features": {
                    "keywords": [
                        "Alcon",
                        "clearly"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-02",
                "original_text": "Analysts Predict 13% Upside For The Holdings of ADRD",
                "features": {
                    "keywords": [
                        "analysts",
                        "upside",
                        "ADRD"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-26",
                "original_text": "Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug",
                "features": {
                    "keywords": [
                        "Amgen",
                        "FDA",
                        "osteoporosis",
                        "drug"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-15",
                "original_text": "Q1 Cannabis Wholesale Report: Best-Selling Brands And Products, Pharma, CBD And Interstate Commerce",
                "features": {
                    "keywords": [
                        "cannabis",
                        "wholesale",
                        "brands",
                        "CBD",
                        "interstate commerce"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "cannabis",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}